Norwegian version of this page

PharmaTox

The PharmaTox Strategic Research Initiative aims to generate novel insight on effects of pharmaceuticals on human neurotoxicity and neurodevelopment.

PharmaTox was established January 1st 2015 as a prioritized research initiative supported by the Faculty of Mathematics and Natural Sciences.

The research projects within PharmaTox involve specialists in neurotoxicology, pharmacology, teratology, statistics, bioinformatics, epigenetics and epidemiology.

News

Tags: Neurotoxicology, Neuroscience, Pharmacy, Toxicology, Bioinformatics, Biostatistics, Epigenetics
Published Feb. 24, 2015 6:17 PM - Last modified Aug. 16, 2017 10:05 AM

Contact

Leader

Professor
Hedvig Nordeng
(School of Pharmacy)

Leader team

Professor
Ragnhild Paulsen 
(School of Pharmacy)

Associate Professor 
Geir Kjetil Sandve 
(Department of Informatics)

Principal Investigator
Ragnhild Eskeland
(Department of Biosciences)

Professor
Sven Ove Samuelsen
(Department of Mathematics)

Senior researcher
Robert Lyle
(School of Pharmacy)